A Vaccine Patch Could Someday Be An Ouchless Option
Mark Prausnitz is director of the Center for Drug Design, Development and Delivery at Georgia Tech. He works on something called microneedle patches to deliver vaccines. So far, he's developed patch vaccines for flu and measles, but the technology could be used for a COVID-19 vaccine as well.
Breaching the Blood-brain Barrier to Deliver Precious Payloads
RNA-based drugs have the potential to change the standard of care for many diseases, making personalized medicine a reality. This rapidly expanding class of therapeutics are cost-effective, fairly easy to manufacture, and able to go where no drug has gone before, reaching previously undruggable pathways.
Dolphin Skincare: How These Sea Mammals Seem to Self-Medicate Their Skin
For skin care like a cetacean, you’re going to need corals, sponges and the ability to hold your breath for a long time.
Origin of Life Theory Involving RNA-Protein Hybrid Gets New Support
A structure that links amino acids suggests that early organisms could have been based on an RNA-protein mix
Protein Gel Could Help Treat Type 1 Diabetes
The gel, which was implanted alongside a pancreatic cell transplant in monkeys with type 1 diabetes, releases a protein that kills overactive immune cells, preventing the pancreatic cells from being rejected